Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammaplasty | 23 | 2024 | 1269 | 3.830 |
Why?
|
Breast Implantation | 10 | 2021 | 225 | 2.930 |
Why?
|
Mastectomy | 20 | 2024 | 1862 | 2.180 |
Why?
|
Tissue Expansion | 5 | 2021 | 163 | 1.350 |
Why?
|
Breast Implants | 12 | 2024 | 414 | 1.350 |
Why?
|
Surgical Flaps | 8 | 2019 | 1682 | 1.280 |
Why?
|
Breast Neoplasms | 21 | 2024 | 21207 | 0.790 |
Why?
|
Postoperative Complications | 12 | 2021 | 15833 | 0.770 |
Why?
|
Nipples | 4 | 2021 | 227 | 0.690 |
Why?
|
Surgical Wound Infection | 5 | 2017 | 1546 | 0.640 |
Why?
|
Esthetics | 2 | 2017 | 330 | 0.550 |
Why?
|
Thoracic Wall | 2 | 2016 | 204 | 0.490 |
Why?
|
Rectus Abdominis | 2 | 2018 | 102 | 0.490 |
Why?
|
Patient Satisfaction | 6 | 2018 | 3490 | 0.480 |
Why?
|
Tissue Expansion Devices | 5 | 2019 | 160 | 0.470 |
Why?
|
Seroma | 1 | 2013 | 75 | 0.430 |
Why?
|
Collagen | 2 | 2021 | 2645 | 0.410 |
Why?
|
Hodgkin Disease | 1 | 2020 | 1384 | 0.400 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2024 | 1791 | 0.400 |
Why?
|
Wound Healing | 2 | 2017 | 2815 | 0.380 |
Why?
|
Breast Cyst | 1 | 2009 | 8 | 0.320 |
Why?
|
Hyperprolactinemia | 1 | 2009 | 124 | 0.300 |
Why?
|
Sodium Chloride | 3 | 2016 | 584 | 0.250 |
Why?
|
Follow-Up Studies | 11 | 2021 | 39354 | 0.250 |
Why?
|
Treatment Outcome | 15 | 2024 | 65379 | 0.230 |
Why?
|
Epigastric Arteries | 2 | 2018 | 93 | 0.230 |
Why?
|
Milk, Human | 1 | 2009 | 490 | 0.230 |
Why?
|
Carbon Dioxide | 3 | 2016 | 1148 | 0.210 |
Why?
|
Middle Aged | 28 | 2024 | 223487 | 0.210 |
Why?
|
Logistic Models | 5 | 2017 | 13290 | 0.210 |
Why?
|
Fat Necrosis | 2 | 2013 | 60 | 0.200 |
Why?
|
Retrospective Studies | 15 | 2020 | 81760 | 0.200 |
Why?
|
Adult | 27 | 2024 | 223646 | 0.190 |
Why?
|
Biocompatible Materials | 1 | 2010 | 1703 | 0.190 |
Why?
|
Ischemia | 1 | 2010 | 1900 | 0.190 |
Why?
|
Female | 33 | 2024 | 397187 | 0.170 |
Why?
|
Facial Injuries | 2 | 2011 | 191 | 0.170 |
Why?
|
Facial Transplantation | 2 | 2011 | 221 | 0.160 |
Why?
|
Thyroglobulin | 1 | 1998 | 111 | 0.150 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2019 | 150 | 0.140 |
Why?
|
Dizocilpine Maleate | 1 | 2017 | 171 | 0.140 |
Why?
|
Body Mass Index | 2 | 2012 | 13053 | 0.140 |
Why?
|
Humans | 39 | 2024 | 768171 | 0.130 |
Why?
|
Skin | 1 | 2010 | 4505 | 0.130 |
Why?
|
Choline | 1 | 2017 | 522 | 0.120 |
Why?
|
Carcinoma, Lobular | 1 | 2019 | 480 | 0.120 |
Why?
|
Reoperation | 2 | 2017 | 4329 | 0.120 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2016 | 260 | 0.110 |
Why?
|
Ginsenosides | 1 | 2013 | 12 | 0.110 |
Why?
|
Explosions | 1 | 2013 | 106 | 0.110 |
Why?
|
Surgery Department, Hospital | 1 | 2013 | 170 | 0.100 |
Why?
|
Membrane Microdomains | 1 | 2013 | 205 | 0.100 |
Why?
|
Thyroid Gland | 1 | 1998 | 1171 | 0.100 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2019 | 1099 | 0.100 |
Why?
|
Time Factors | 4 | 2017 | 40220 | 0.090 |
Why?
|
Aged | 13 | 2024 | 171502 | 0.090 |
Why?
|
Terrorism | 1 | 2013 | 211 | 0.090 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 434 | 0.090 |
Why?
|
Cattle | 1 | 2016 | 3819 | 0.090 |
Why?
|
Burns, Electric | 1 | 2011 | 40 | 0.090 |
Why?
|
Prospective Studies | 6 | 2021 | 54924 | 0.090 |
Why?
|
Risk Factors | 5 | 2017 | 74944 | 0.090 |
Why?
|
Memory Disorders | 1 | 2017 | 1200 | 0.090 |
Why?
|
Blast Injuries | 1 | 2013 | 321 | 0.090 |
Why?
|
Hernia, Abdominal | 1 | 2010 | 58 | 0.080 |
Why?
|
Presenilin-1 | 1 | 2013 | 666 | 0.080 |
Why?
|
Trans-Activators | 1 | 1998 | 2857 | 0.080 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2013 | 616 | 0.080 |
Why?
|
Disaster Planning | 1 | 2013 | 559 | 0.070 |
Why?
|
Catgut | 1 | 2007 | 6 | 0.070 |
Why?
|
Memory | 1 | 2017 | 2207 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 1998 | 5797 | 0.070 |
Why?
|
Postoperative Care | 1 | 2013 | 1480 | 0.070 |
Why?
|
Surgical Mesh | 1 | 2010 | 315 | 0.070 |
Why?
|
Surgery, Plastic | 1 | 2013 | 652 | 0.070 |
Why?
|
Cohort Studies | 4 | 2017 | 41753 | 0.070 |
Why?
|
Graft Rejection | 4 | 2016 | 4492 | 0.070 |
Why?
|
Necrosis | 1 | 2010 | 1616 | 0.060 |
Why?
|
Comorbidity | 2 | 2010 | 10590 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 1998 | 2360 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2862 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2539 | 0.060 |
Why?
|
Hippocampus | 1 | 2017 | 3783 | 0.060 |
Why?
|
Medical Records | 1 | 2010 | 1410 | 0.060 |
Why?
|
Risk Assessment | 3 | 2017 | 24318 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 969 | 0.060 |
Why?
|
Graft Survival | 2 | 2016 | 3887 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 1998 | 5804 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12077 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21538 | 0.050 |
Why?
|
Young Adult | 5 | 2019 | 60066 | 0.050 |
Why?
|
Adolescent | 5 | 2017 | 89169 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2017 | 59626 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6986 | 0.050 |
Why?
|
Suture Techniques | 1 | 2007 | 775 | 0.050 |
Why?
|
Low Back Pain | 1 | 2010 | 990 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 1998 | 9617 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2011 | 2907 | 0.040 |
Why?
|
Genes, myc | 2 | 1998 | 391 | 0.040 |
Why?
|
Transcription Factors | 1 | 1998 | 12171 | 0.040 |
Why?
|
Paired Box Transcription Factors | 1 | 1998 | 206 | 0.040 |
Why?
|
Odds Ratio | 1 | 2010 | 9669 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1998 | 412 | 0.030 |
Why?
|
Insufflation | 1 | 2016 | 64 | 0.030 |
Why?
|
Neurotoxins | 1 | 2017 | 240 | 0.030 |
Why?
|
Prognosis | 2 | 2019 | 30009 | 0.030 |
Why?
|
United States | 2 | 2021 | 73039 | 0.030 |
Why?
|
Genes, BRCA2 | 1 | 2017 | 593 | 0.030 |
Why?
|
Transfection | 2 | 1998 | 5756 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2017 | 755 | 0.030 |
Why?
|
Age Factors | 1 | 2010 | 18415 | 0.030 |
Why?
|
Smoking | 1 | 2010 | 9092 | 0.030 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2013 | 123 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 1998 | 998 | 0.030 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2013 | 199 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2013 | 303 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2013 | 497 | 0.020 |
Why?
|
Cricetulus | 1 | 2013 | 812 | 0.020 |
Why?
|
Quality of Life | 2 | 2024 | 13490 | 0.020 |
Why?
|
Animals | 5 | 2017 | 169285 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3620 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6124 | 0.020 |
Why?
|
CHO Cells | 1 | 2013 | 1379 | 0.020 |
Why?
|
Rosacea | 1 | 2011 | 60 | 0.020 |
Why?
|
Cricetinae | 1 | 2013 | 2423 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2013 | 751 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2013 | 3056 | 0.020 |
Why?
|
Motor Activity | 1 | 2017 | 2711 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3590 | 0.020 |
Why?
|
Gestational Age | 1 | 2016 | 3621 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1997 | 2846 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 2011 | 575 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3772 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8142 | 0.020 |
Why?
|
Glucose | 1 | 1998 | 4352 | 0.020 |
Why?
|
Pregnancy | 2 | 2017 | 30255 | 0.010 |
Why?
|
Apoptosis | 2 | 1998 | 9527 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1998 | 12801 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 4834 | 0.010 |
Why?
|
Patient Care Team | 1 | 2013 | 2523 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2011 | 3556 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2337 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9419 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9343 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9374 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9561 | 0.010 |
Why?
|
Amyloid beta-Peptides | 1 | 2013 | 3914 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8890 | 0.010 |
Why?
|
Aging | 1 | 2017 | 8743 | 0.010 |
Why?
|
Deoxyglucose | 1 | 1998 | 333 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11244 | 0.010 |
Why?
|
Male | 4 | 2017 | 364731 | 0.010 |
Why?
|
Glycolysis | 1 | 1998 | 837 | 0.010 |
Why?
|
Neurons | 1 | 2013 | 9514 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 1169 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1997 | 4168 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1998 | 1406 | 0.010 |
Why?
|
Mice | 2 | 2013 | 82049 | 0.010 |
Why?
|
Cell Division | 1 | 1997 | 4477 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13677 | 0.000 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 1998 | 2956 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1998 | 19025 | 0.000 |
Why?
|
Rats | 1 | 1998 | 23782 | 0.000 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1997 | 8648 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1997 | 11677 | 0.000 |
Why?
|
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_